GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guardant Health Inc (MEX:GH) » Definitions » Other Gross PPE

Guardant Health (MEX:GH) Other Gross PPE : MXN5,127 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Guardant Health Other Gross PPE?

Guardant Health's Other Gross PPE for the quarter that ended in Dec. 2024 was MXN5,127 Mil.

Guardant Health's quarterly Other Gross PPE increased from Jun. 2024 (MXN4,566 Mil) to Sep. 2024 (MXN4,891 Mil) and increased from Sep. 2024 (MXN4,891 Mil) to Dec. 2024 (MXN5,127 Mil).

Guardant Health's annual Other Gross PPE declined from Dec. 2022 (MXN5,338 Mil) to Dec. 2023 (MXN4,412 Mil) but then increased from Dec. 2023 (MXN4,412 Mil) to Dec. 2024 (MXN5,127 Mil).


Guardant Health Other Gross PPE Historical Data

The historical data trend for Guardant Health's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardant Health Other Gross PPE Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only 1,419.89 4,680.17 5,337.65 4,411.84 5,127.04

Guardant Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,411.84 4,226.34 4,566.05 4,890.74 5,127.04

Guardant Health Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Guardant Health Business Description

Traded in Other Exchanges
Address
3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.